ESTRO 2024 - Abstract Book

S5890

RTT - Service evaluation, quality assurance and risk management

ESTRO 2024

Future analyses will provide more in-depth insight of treatment techniques enabling further improvement where indicated.

Keywords: Breast, variation, radiotherapy

References:

1. Locke I, Drinkwater K. Implementation of Royal College of Radiologists Consensus Statements and National Institute for Health and Care Excellence Guidance: Breast Radiotherapy Practice in the UK. Clin Oncol (R Coll Radiol). 2021 Jul;33(7):419-426. 2. Royal College of Radiologists (RCR). Postoperative radiotherapy for breast cancer: UK consensus statements. 2016. Available at: https://www.rcr.ac.uk/clinical-oncology/service-delivery/postoperative-radiotherapy-breast-cancer-uk consensusstatements (Accessed: 10 October 2023). 3. National Institute for Health and Care Excellence (NICE). Early and locally advanced breast cancer: diagnosis and management. NICE guideline [NG101]. 2018. Available at: https://www.nice.org.uk/guidance/ng101 (Accessed: 10 October 2023). 4. Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. FAST-Forward Trial Management Group. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, noninferiority, randomised, phase 3 trial. Lancet. 2020; 395(10237):1613e1626. 5. Bartlett FR, Colgan RM, Carr K, Donovan EM, McNair HA, Locke I, et al. The UK HeartSpare Study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy. Radiother Oncol. 2013;108(2): 242e247. 6. Coles CE, Griffin CL, KirbyAM, Titley J, Agrawal RK, AlhassoA, et al. IMPORT Trialists. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet. 2017;390(10099): 1048e1060. 7. Thorsen LB, Offersen BV, Danø H, Berg M, Jensen I, Pedersen AN, et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol . 2016;34(4): 314e320.

8. Kindts I, Laenen A, Depuydt T, Weltens C. Tumour bed boost radiotherapy for women after breast-conserving surgery. Cochrane Database Syst Rev . 2017 Nov 6;11(11):CD011987.

9. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med . 2013;368(11):987e998.

10. Royal College of Radiologists (RCR). Summary Report of the Results of the Royal College of Radiologists’ National Breast Radiotherapy Audit. 2013. Available at: https://www.rcr.ac.uk/system/files/breast_audit_amended_28052013.pdf (Accessed: 10 October 2023).